Position in RDNT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$708,014
-$188,356 QoQ
Shares Held
12,668
+0.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Summit Financial, LLC holds $6,969,585 across 7 Diagnostics & Research names. RDNT ranks #5 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,555 | $1,747,389 | |
| 2 | GRAL |
GRAIL, Inc.
|
30,267 | $1,564,198 | |
| 3 | DHR |
Danaher Corp /De/
|
6,521 | $1,236,381 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,464 | $822,606 | |
| 5 | RDNT |
RadNet, Inc.
This page
|
12,668 | $708,014 | |
| 6 | DGX |
Quest Diagnostics Inc
|
2,483 | $486,618 | |
| 7 | NTRA |
Natera, Inc.
|
2,022 | $404,379 |
All Filings in RDNT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $708,014 | 12,668 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $896,370 | 12,563 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $944,775 | 12,397 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $651,050 | 11,440 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $557,808 | 11,219 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $775,992 | 11,111 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $752,812 | 10,849 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $616,715 | 10,467 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $455,262 | 9,356 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||